Radioiodine News and Research

RSS
Iodine-131 (131I), also called radioiodine (though many other radioactive isotopes of this element are known), is an important radioisotope of iodine. It has a radioactive decay half life of about eight days. Its uses are mostly medical and pharmaceutical.
New York State Department of Health issues license to Veracyte's Afirma Gene Expression Classifier

New York State Department of Health issues license to Veracyte's Afirma Gene Expression Classifier

Vandetanib shows efficacy in thyroid cancer

Vandetanib shows efficacy in thyroid cancer

First detailed analysis of Fukushima Daiichi nuclear disaster's global health effects

First detailed analysis of Fukushima Daiichi nuclear disaster's global health effects

SPECT/CT can change clinical management of thyroid cancer

SPECT/CT can change clinical management of thyroid cancer

HiLo trial sets new gold standard for thyroid cancer treatment

HiLo trial sets new gold standard for thyroid cancer treatment

New way to exploit expression of BRAF by papillary carcinomas for therapeutic purposes

New way to exploit expression of BRAF by papillary carcinomas for therapeutic purposes

Glitazone treatment does not cause side effects in patients with metastatic thyroid cancer

Glitazone treatment does not cause side effects in patients with metastatic thyroid cancer

Researchers explore novel therapeutic approach for thyroid cancer

Researchers explore novel therapeutic approach for thyroid cancer

Lenvatinib may achieve partial response in thyroid, endometrial, and renal cancers

Lenvatinib may achieve partial response in thyroid, endometrial, and renal cancers

ATA announces five recipients of 2011 thyroid cancer research grants

ATA announces five recipients of 2011 thyroid cancer research grants

Radioiodine being overused in thyroid cancer: Study

Radioiodine being overused in thyroid cancer: Study

New method uses ICP-MS system to identify radioactive elements in environment

New method uses ICP-MS system to identify radioactive elements in environment

Preliminary results from Eisai's lenvatinib Phase II trial in thyroid cancer to be presented at ASCO 2011

Preliminary results from Eisai's lenvatinib Phase II trial in thyroid cancer to be presented at ASCO 2011

Research on rare cancers

Research on rare cancers

New ATA recommendations on outpatient 131I therapy aim to treat thyroid cancer

New ATA recommendations on outpatient 131I therapy aim to treat thyroid cancer

International Isotopes 2010 net loss increases 49% to $6,802,014

International Isotopes 2010 net loss increases 49% to $6,802,014

Low levels of radioactivity from Japan may affect sensitive physics experiments in the U.S.

Low levels of radioactivity from Japan may affect sensitive physics experiments in the U.S.

Iodine 131 exposure during childhood increases risk of developing thyroid cancer

Iodine 131 exposure during childhood increases risk of developing thyroid cancer

Experts issue joint statement to help Americans understand radiation-related health risks

Experts issue joint statement to help Americans understand radiation-related health risks

Radiations from Japanese nuclear plants do not pose immediate risk to the U.S.

Radiations from Japanese nuclear plants do not pose immediate risk to the U.S.